TABLE 2

FROM:

Impairment of phenylalanine conversion to tyrosine inend-stage renal disease causing tyrosine deficiency

YVES BOIRIE, ROBERT ALBRIGHT, MAUREEN BIGELOW and K SREEKUMARAN NAIR

Table 2. Anthropometric, clinical, and biologic data of the population

	Controls	End-stage renal disease
Age years	53.83 5.16	53.50 4.88
Weight kg	83.17 6.99	79.37 6.77
Body mass index kg/m2	25.93 1.73	26.26 2.14
Fat-free mass kg	59.73 3.43	53.87 3.00
Muscle mass kg	36.67 2.63	30.36 2.02a
Fat mass %	22.14 2.64	24.45 4.21
Duration of hemodialysis years	—	4.25 1.49
Glucose mg/dL	98.08 1.55	93.25 4.46
Bicarbonate mEq/L	26.33 0.99	26.00 0.65
Blood urea nitrogen mg/dL	17.33 1.41	33.00 3.92a
Creatinine mg/dL	1.18 0.03	7.52 0.33a
Serum albumin level g/dL	4.5 0.13	3.9 0.13
Length of dialysis session minutes	—	240 15
Urea reduction ratio %	—	72 2.62
Hemoglobin g/dL	14.6 0.32	11.7 0.43a

 Mean SD.

^a  P < 0.05 end stage renal disease vs. control subjects.